Roche Pauses Shipments of Contested Gene Therapy Outside the US
The Swiss drugmaker said the pause effective today applies to new orders of Elevidys in countries outside the U.S. that base their approvals off Food and Drug Administration decisions. It covers all patients with Duchenne muscular dystrophy regardless of their ability to walk. It's voluntary and temporary, the company said in an emailed statement.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
USA Swimming confirms stomach bug impacting team at worlds
USA Swimming has confirmed reports that some team members competing in the World Aquatics Championships in Singapore were recovering from acute gastroenteritis, US public broadcaster NPR reported. USA Swimming senior communications director Nikki Warner said in a statement cited by NPR that "those experiencing symptoms" were receiving treatment, without saying which swimmers were affected or how they got sick. The team's medical staff was also "advising the team on further preventative and recovery measures," Warner added. The team is "planning to race and perform to the best of our ability for the rest of the meet," Warner said, according to NPR. Acute gastroenteritis, an inflammation of the stomach and intestines, is usually caused by viruses such as Norovirus or bacteria such as On Saturday, Paris 100 metre butterfly gold medallist Torri Huske did not swim the 100m butterfly "to prioritize her efforts in the 4x100m freestyle relay," USA Swimming said. The relay, which had been favoured to win and was anchored by Huske, came second behind Australia on Sunday evening. Claire Weinstein also pulled out of the 400 metre freestyle. Several US swimmers performed below expectations on Sunday and on Monday morning.
Yahoo
25 minutes ago
- Yahoo
MrFluffyFriend Launches XXXXL Calming Dog Bed for Large and Anxious Dogs
Over 600,000 dogs sleep better already — now available in 48 inch (120cm) & 56 inch (140cm) with up to 60% off and free shipping on Image by MrFluffyFriend LOS ANGELES, July 27, 2025 (GLOBE NEWSWIRE) -- MrFluffyFriend, a fast-growing U.S. pet wellness brand known for its calming products, announces the launch of its XXXXL Calming Dog Bed, specially designed for large breeds and dogs prone to anxiety. The oversized beds, now available in 120cm and 140cm, offer unmatched comfort and emotional relief thanks to premium materials and calming features rooted in behavioral science. Made with ultra-soft vegan faux fur, deep orthopedic padding, and a raised rim for added head and neck support, the XXXXL Calming Bed creates a soothing nest-like environment that helps dogs feel safe, supported, and calm — especially during fireworks, thunderstorms, or when left home alone. 'We've helped over 600,000 dogs sleep better with our calming beds,' says a MrFluffyFriend spokesperson. 'Our community asked for something big enough for their Labradors, Golden Retrievers, Huskies — and we listened. This launch is all about showing that big dogs deserve big comfort, too.' According to veterinarians, over 70% of dogs experience anxiety at some point, which can lead to restlessness, whining, and destructive behavior. MrFluffyFriend's calming design mimics a mother's touch, helping to trigger the release of serotonin and reduce stress naturally. Key Features: Sizes: XXXL (48 in / 120 cm) and XXXXL (56 in / 140 cm) Raised rim for orthopedic support and security Ultra-soft faux fur mimics a mother's touch Machine washable cover + water-resistant, non-slip base Hypoallergenic and pet-safe materials Ideal for large breeds and multi-dog households The launch is accompanied by a limited-time offer of up to 60% off, free shipping across the U.S., and a 30-day risk-free trial, making it easier than ever for pet parents to try the product. Early feedback has been overwhelmingly positive, with customers praising the bed's luxurious size, fluffiness, and noticeable calming effect. Some report their dogs sleep longer, bark less, and even retreat to the bed during stressful moments like vet visits or fireworks. About MrFluffyFriend Founded with a mission to help pets feel safe, calm, and loved, MrFluffyFriend is a pet lifestyle brand trusted by dog lovers in over 25 countries. From calming beds to wellness accessories, every product is developed with science-backed design and premium materials to ensure pets thrive — emotionally and physically. Learn more at Media Contact: Thomas, H. info@ A photo accompanying this announcement is available at in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
25 minutes ago
- Yahoo
Earnings To Watch: NMI Holdings (NMIH) Reports Q2 Results Tomorrow
Mortgage insurance provider NMI Holdings (NASDAQ:NMIH) will be reporting results this Tuesday after the bell. Here's what you need to know. NMI Holdings beat analysts' revenue expectations by 3% last quarter, reporting revenues of $173.2 million, up 10.9% year on year. It was an exceptional quarter for the company, with a solid beat of analysts' net premiums earned estimates and a solid beat of analysts' EPS estimates. Is NMI Holdings a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting NMI Holdings's revenue to grow 7.6% year on year to $174.4 million, slowing from the 13.6% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.19 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. NMI Holdings has only missed Wall Street's revenue estimates once over the last two years, exceeding top-line expectations by 1.2% on average. Looking at NMI Holdings's peers in the property & casualty insurance segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Stewart Information Services delivered year-on-year revenue growth of 20.1%, beating analysts' expectations by 9.2%, and First American Financial reported revenues up 14.2%, topping estimates by 4.9%. Stewart Information Services traded up 10.3% following the results while First American Financial was also up 3.5%. Read our full analysis of Stewart Information Services's results here and First American Financial's results here. Debates over possible tariffs and corporate tax adjustments have raised questions about economic stability in 2025. While some of the property & casualty insurance stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 3.5% on average over the last month. NMI Holdings is down 9.9% during the same time and is heading into earnings with an average analyst price target of $43.71 (compared to the current share price of $38). When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we've found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
